Oaknet Healthcare Pvt. Ltd.

Based in India, Oaknet Healthcare Pvt. Ltd. specializes in developing and manufacturing pharmaceutical products aimed at improving health outcomes across various therapeutic areas in both domestic and select international markets. Founded in 2011 and headquartered in Bangalore, India, Oaknet Healthcare Pvt.

Ltd. focuses on the development and manufacturing of pharmaceutical products. The company has completed a total of 3 deals, with the most recent deal occurring on May 4, 2022. Its latest funding round raised INR 5,500 mn from investors including Adcock Ingram Holdings, bringing the total amount raised to INR 5,500 mn and valuing the company at approximately INR 6,561.

23 mn. The company was co-founded by Andrea Guglielmo and Nadia Innocenti, with Andrea Guglielmo currently serving as CEO. Oaknet Healthcare Pvt. Ltd.

primarily focuses on developing and manufacturing a diverse range of pharmaceutical products that cater to various therapeutic areas, including Dermatology, Gynaecology, Pain Management, Nutritional support, Cardiology, and Diabetes management. The company's core product offerings are designed to improve patient health outcomes by providing high-quality medications and innovative therapies targeted at healthcare providers, hospitals, and clinics in India and select international markets. In 2023, Oaknet Healthcare generated revenue of INR 31,194,062. 70 and reported an EBITDA of INR 7,590,311.

The company maintains a structured business model that includes B2B transactions with healthcare providers and direct-to-consumer sales, ensuring a steady cash flow through partnerships with distributors and retailers. Following the acquisition of Oaknet Healthcare by Eris Lifesciences Limited, which was finalized in May 2022 for INR 6,500 mn, the company aims to enhance its presence in the dermatology segment. Future growth strategies include the development of new pharmaceutical products tailored for this market, with specific release dates yet to be announced. The recent funding will support these initiatives and facilitate Oaknet's expansion into broader markets, particularly within India and potentially into Southeast Asia, leveraging Eris Lifesciences Limited's extensive distribution network.